Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice

Neuropeptides

Volumn 39, Issue 3, 2005, Pages 233-237

  Mufson, Elliott J ^a   Counts, Scott E ^a   Perez, Sylvia E ^a   Binder, L ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's; Amyloid; Basal forebrain; Cholinergic; Galanin; Tau; Transgenic

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GALANIN; NEUROPEPTIDE; PRESENILIN 1; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; BRAIN CORTEX; CELL LOSS; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONFERENCE PAPER; DNA MICROARRAY; DOWN REGULATION; FOREBRAIN; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; INNERVATION; MUTAGENESIS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER; NEURITE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

ACETYLCHOLINE; ALZHEIMER DISEASE; ANIMALS; GALANIN; HUMANS; MICE; MICE, TRANSGENIC; PROSENCEPHALON;

MUS MUSCULUS;

EID: 20444363135     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2004.12.005     Document Type: Conference Paper

References (29)

1. T. Bartfai, U. Langel, K. Bedecs, S. Andell, T. Land, S. Gregersen, B. Ahren, P. Girotti, S. Consolo, and R. Corwin Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes Proc. Natl. Acad. Sci. USA 90 1993 11287 11291
2. W.C. Benzing, J.H. Kordower, and E.J. Mufson Galanin immunoreactivity within the primate basal forebrain: evolutionary change between monkeys and apes J. Comp. Neurol. 336 1993 31 39
3. R. Bowser, J.H. Kordower, and E.J. Mufson A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease Brain Pathol. 7 1997 723 730
4. J.P. Brion, D.P. Hanger, A.M. Couck, and B.H. Anderton A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosophorylated state which affect their electrophoretic mobilities Biochem. J. 279 1991 831 836
5. V. Chan-Palay Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia J. Comp. Neurol. 273 1988 543 557
6. Counts, S.E., Chen, E.Y., Ikonomovic, M.D., Wuu, J., Cochran, E.J., Bennett, D.A., Levey, A.I., Kordower, J.H., DeKosky, S.T., Mufson, E.J., 2002. Galanin plasticity within the nucleus basalis in people with mild cognitive impairment. Neurosci. Abstr
7. S.E. Counts, S.E. Perez, U. Kahl, T. Bartfai, R. Bowser, D.C. Deecher, D.C. Mash, J.N. Crawley, and E.J. Mufson Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease CNS Rev. (peer reviewed) 7 2001 445 470
8. S.E. Counts, E. Sylvia, S.E. Perez, S.D. Ginsberg, S. de Lacalle, and E.J. Mufson Galanin plasticity in Alzheimer's disease Mol. Intervention 3 2003 137 156
9. J.N. Crawley, E.J. Mufson, J. Hohmann, D. Teklemichael, R.A. Steiner, K. Holmberg, H. Blakeman, X-J. Xu, Z. Wiesenfeld-Halln, T. Bartfai, and T. Hökfelt Galanin overexpressing transgenic mice Neuropeptides 36 2002 145 156
10. M. Diez, J. Koistinaho, K. Kahn, D. Games, and T. Hokfelt Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F β-amyloid precursor protein-initial observations Neuroscience 100 2000 259 286
11. G. Fisone, T. Bartfai, S. Nilsson, and T. Hokfelt Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus Brain. Res. 568 1991 279 284
12. F. García-Sierra, N. Ghoshal, B. Quinn, R.W. Berry, and L.I. Binder Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease J. Alzheimer's Dis. 5 2003 65 77
13. N. Ghoshal, F. Garcia-Sierra, Y. Fu, L.A. Beckett, E.J. Mufson, J. Kuret, R.W. Berry, and L.I. Binder Tau-66: evidence for a novel tau conformation in Alzheimer's disease J. Neurochem. 77 2001 1372 1385
14. M.L. Gilmore, J.D. Erickson, H. Varoqui, L.B. Hersh, D.A. Bennett, E.J. Cochran, E.J. Mufson, and A.I. Levey Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease J. Comp. Neurol. 411 1999 693 704
15. T. Hokfelt, C. Broberger, M. Diez, Z.Q. Xu, T. Shi, J. Kopp, X. Zhang, K. Holmberg, M. Landry, and J. Koistinaho Galanin and NPY, two peptides with multiple putative roles in the nervous system Horm. Metab. Res. 31 5 1999 330 334
16. K.S. Kosik, C.L. Joachim, and D.J. Selkoe Microtubule-associated protein tau a major antigenic component of paired helical filaments in Alzheimer's disease Proc. Natl. Acad. Sci. USA 83 1986 4044 4048
17. N.W. Kowall, and M.F. Beal Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease Neurosci. Lett. 98 1989 118 123
18. O. Lazarov, M. Lee, D.A. Peterson, and S.S. Sisodia Evidence that synaptically released β-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice J. Neurosci. 22 2002 9785 9793
19. T. Melander, T. Hokfelt, and A. Rokaeus Distribution of galanin like immunoreactivity in the rat central nervous system J. Comp. Neurol. 248 1986 475 517
20. M-M. Mesulam, E.J. Mufson, A.I. Levey, and B.H. Wainer Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkey J. Comp. Neurol. 214 1983 170 197
21. E.J. Mufson, E. Cochran, W.C. Benzing, and J.H. Kordower Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome Dementia 4 1993 237 250
22. Mufson, E.J., Kordower, J.H., (Eds.), 2000. Cholinergic Basal Forebrain Systems in the Primate Central Nervous System: Anatomy, Connectivity, Neurochemistry, Aging, Dementia and Experimental Therapeutics. In: Hof, P.R., Moobs C.V. (Eds.), Functional Neurobiology of Aging. Academic Press, San Diego, pp. 243-276
23. Perez, S.E., Lazarov, O., Rodriguez, V., Sisodia, S.S., Mufson, E.J., 2004. Axonal dystrophy in cholinergic, galaninergic and dopaminergic projection systems in APPswe/PS1Δ E9 transgenic mice. In: World Conference on Alzheimer's Disease, Philadelphia (Abstr.)
24. T.J. Sendera, S.Y. Ma, S. Jaffar, P.B. Kozlowski, J.H. Kordower, Y. Mawal, H.U. Saragovi, and E.J. Mufson Reduction in trkA immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome J. Neurochem. 74 2000 1185 1196
25. R.A. Steiner, J.G. Hohmann, A. Holmes, C.C. Wrenn, G. Cadd, A. Juréus, D.K. Clifton, M. Luo, M. Gutshall, S.Y. Ma, E.J. Mufson, and J.N. Crawley Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's Disease Proc. Natl. Acad. Sci. USA 98 2001 4184 4189
26. K. Tatemoto, A. Rokaeus, H. Jornvall, T.J. McDonald, and V. Mutt Galanin - a novel biologically active peptide from porcine intestine FEBS Lett. 164 1983 124 128
27. C.C. Wrenn, L.K. Marriott, J.W. Kinney, A. Holmes, G.L. Wenk, and J.N. Crawley Galanin peptide levels in hippocampus and cortex of galanin- overexpressing transgenic mice evaluated for cognitive performance Neuropeptides 36 2002 413 426
28. D. Wynick, and A. Bacon Targeted disruption of galanin: new insights from knock-out studies Neuropeptides 36 2002 132 144
29. X.J. Xu, T. Hokfelt, T. Bartfai, and Z. Wiesenfeld-Hallin Galanin and spinal nociceptive mechanisms: recent advances and therapeutic implications Neuropeptides 34 3-4 2000 137 147